TOUYUN BIOTECH GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.235 HKD | 0.00% |
|
+2.17% | +2.17% |
| Apr. 30 | China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders | MT |
| Mar. 28 | Touyun Biotech Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 316M 40.41M | Sales 2023 | 199M 25.42M | Capitalization | 645M 82.59M |
|---|---|---|---|---|---|
| Net income 2022 | -198M -25.34M | Net income 2023 | -269M -34.42M | EV / Sales 2022 | 4.93 x |
| Net Debt 2022 | 351M 44.93M | Net Debt 2023 | 454M 58.15M | EV / Sales 2023 | 5.54 x |
| P/E ratio 2022 |
-6.09
x | P/E ratio 2023 |
-2.4
x | Employees | 566 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.35% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | +2.17% | ||
| Current month | +2.17% | ||
| 1 month | -0.84% | ||
| 3 months | -6.00% | ||
| 6 months | -48.35% | ||
| Current year | +2.17% |
1 week
0.23
0.24
1 month
0.130.24
Current year
0.130.28
1 year
0.130.68
3 years
0.131.69
5 years
0.131.75
10 years
0.112.78
| Managers | Title | Age | Since |
|---|---|---|---|
Li Ang Wang
CHM | Chairman | 38 | 16-08-31 |
On Lok Li
SEC | Corporate Secretary | 44 | 22-08-01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kee Choy Ha
BRD | Director/Board Member | 67 | 14-11-25 |
Shing Chuen To
BRD | Director/Board Member | 73 | 14-11-25 |
Wing Ping Cheung
BRD | Director/Board Member | 57 | 15-08-10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 0.235 | 0.00% | 0 |
| 24-05-08 | 0.235 | -2.08% | 0 |
| 24-05-07 | 0.24 | 0.00% | 0 |
| 24-05-06 | 0.24 | +4.35% | 43,125 |
| 24-05-03 | 0.23 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., May 09, 2024 at 04:08 am EDT
More quotes
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, is an investment holding company principally engaged in the manufacture and sales of packaging products. Along with subsidiaries, the Company operates its business through four segments. The Packaging Products segment is engaged in the production and sale of manufacture and sale of watch boxes, jewelry boxes, eyewear cases, bags and pouches and display units. The Quick Response (QR) Code Business segment is engaged in the provision of QR code on product packaging and solutions and advertising display services. The Chlamydomonas Reinhardtii Product Business segment is engaged in the production and sale of chlamydomonas reinhardtii, micro-algae and related products. The Treasury Investment segment is engaged in the investments and trading in securities, money lending, securities brokerage and margin financing.
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +2.17% | 84.35M | |
| +20.99% | 21.69B | |
| +12.14% | 18.13B | |
| -8.78% | 10.03B | |
| +21.46% | 9.57B | |
| +2.20% | 5.39B | |
| +3.20% | 4.96B | |
| -2.15% | 3.02B | |
| +14.18% | 3.01B | |
| -2.70% | 2.32B |
- Stock Market
- Equities
- 1332 Stock